Explore

TrendlineTrendline
Post-Menopausal Women Advised to Adopt Weight-Bearing and Strength Routines for Bone Health

Post-Menopausal Women Advised to Adopt Weight-Bearing and Strength Routines for Bone Health

Post-Menopausal Women Advised to Adopt Weight-Bearing and Strength Routines for Bone Health
Rapid ReadRapid Read
Pharmacogenomics Advances Personalized Medicine by Tailoring Drug Treatments Based on Genetic Information

Pharmacogenomics Advances Personalized Medicine by Tailoring Drug Treatments Based on Genetic Information

Pharmacogenomics is an evolving field that examines how an individual's genetic makeup influences their response to medications. This scientific discipline helps explain why some patients experience different efficacy levels or side effects from the same drug. Organizations such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (DPWG) are instrumental in developing guidelines that link specific genetic variants to treatment and dosing recommendations. The integration of pharmacogenomics into clinical practice is growing, moving towards a more personalized approach to medicine. This involves translating complex genetic data into actionable treatment advice, which requires collaboration among laboratories, pharmacies, bioinformaticians, ICT specialists, and prescribing clinicians. The primary challenge lies in ensuring the reliability, interpretability, and usability of this genetic information for making informed treatment decisions.
TrendlineTrendline
Daily Habits Crucial for Sustained Focus, Balance, and Long-Term Health

Daily Habits Crucial for Sustained Focus, Balance, and Long-Term Health

Daily Habits Crucial for Sustained Focus, Balance, and Long-Term Health
TrendlineTrendline
Compounding Pharmacies Offer Custom Tretinoin Formulations Beyond Standard Commercial Strengths

Compounding Pharmacies Offer Custom Tretinoin Formulations Beyond Standard Commercial Strengths

Compounding Pharmacies Offer Custom Tretinoin Formulations Beyond Standard Commercial Strengths
TrendlineTrendline
Mel Robbins Podcast Features Stanford Urologist on Male Hormone Health

Mel Robbins Podcast Features Stanford Urologist on Male Hormone Health

Mel Robbins Podcast Features Stanford Urologist on Male Hormone Health
TrendlineTrendline
Walking Alone Insufficient for Comprehensive Leg Strength and Balance, Experts Advise Supplemental Exercises

Walking Alone Insufficient for Comprehensive Leg Strength and Balance, Experts Advise Supplemental Exercises

Walking Alone Insufficient for Comprehensive Leg Strength and Balance, Experts Advise Supplemental Exercises
USA TodayUSA Today
Josh Duhamel feels 'stronger' with testosterone. What to know about the therapy

Josh Duhamel feels 'stronger' with testosterone. What to know about the therapy

Josh Duhamel is opening up about his use of testosterone replacement therapy. Experts say it comes with risk. Here's what to know.
TrendlineTrendline
Mobility Training Incorporates Cat-Cow, Squats, and Lunges for Strength and Flexibility

Mobility Training Incorporates Cat-Cow, Squats, and Lunges for Strength and Flexibility

Mobility Training Incorporates Cat-Cow, Squats, and Lunges for Strength and Flexibility
Rapid ReadRapid Read
Postbiotic Urolithin A Shows Promise in Mitophagy Induction, Clinical Trials Underway

Postbiotic Urolithin A Shows Promise in Mitophagy Induction, Clinical Trials Underway

Urolithin A, a postbiotic produced in the gut from ellagitannins found in pomegranates and walnuts, is gaining attention for its ability to induce mitophagy. Mitophagy is a cellular process where damaged mitochondria are selectively removed. According to a review in Nutrients, Urolithin A induces mitophagy through the PINK1/Parkin pathway and has been evaluated in registered human clinical trials. While these trials have measured the activation of tagging systems like PINK1 and Parkin, direct imaging of mitochondrial turnover in living humans has not yet been conducted. The broader context of autophagy supplements often involves measuring upstream pathway activation rather than the actual degradation of cellular components, leading to a 'measurement gap' in the industry. However, Urolithin A stands out for its progress in human clinical trials, focusing on a specific and critical cellular cleanup mechanism.
Rapid ReadRapid Read
U.S. Life Expectancy Rises to 79 Years Post-Pandemic, Focus Shifts to Healthspan

U.S. Life Expectancy Rises to 79 Years Post-Pandemic, Focus Shifts to Healthspan

Life expectancy in the United States has rebounded to 79 years following a decline during the COVID-19 pandemic. This figure, while an improvement, still lags behind comparable countries such as Japan (84 years) and Norway (82 years). Alongside the traditional focus on lifespan—the total number of years lived—medical professionals are increasingly emphasizing 'healthspan.' Healthspan refers to the duration of life lived in good health, free from debilitating diseases or disabilities that limit quality of life. Doctors define lifespan as the chronological age humans can expect to achieve, with an average of about 80 years in the U.S., though it can be slightly lower for men and higher for women. The concept of healthspan highlights the importance of not just living longer, but living healthier for a greater portion of one's life. This shift in focus acknowledges that while medical advancements can extend life, the quality of those extended years is equally crucial.
Rapid ReadRapid Read
HHS Unveils AI Initiatives to Accelerate U.S. Clinical Trials

HHS Unveils AI Initiatives to Accelerate U.S. Clinical Trials

The U.S. Department of Health and Human Services (HHS) has announced a new program and three complementary projects aimed at significantly speeding up clinical trials through the integration of artificial intelligence (AI), advanced computational models, and real-time analysis. The core initiative, named SURPASS (Simulation-augmented, Real-time Platform Adaptive Seamless Trials), seeks to develop AI-powered platforms that will continuously and adaptively support clinical trial designs. This program includes the creation of a phaseless design engine to simulate trials for faster results with fewer patients, a continuous inference engine for real-time data analysis and trial adaptations, and an agentic AI operations layer to automate startup activities and data collection. These efforts are part of a broader strategy by HHS to transform U.S. clinical trials, building on previous initiatives like Operation TrialBlazer and the FDA's pilot program using AI for real-time clinical trial data monitoring. The goal ...
TrendlineTrendline
Chair Exercises Endorsed for Seniors to Boost Strength and Mobility

Chair Exercises Endorsed for Seniors to Boost Strength and Mobility

Chair Exercises Endorsed for Seniors to Boost Strength and Mobility